MAPK4 promotes the proliferation of colon cancer and lung cancer by noncanonical AKT/mTOR,10 while MAPK4 facilitates prostate cancer growth and castration resistance by activating the GATA2/AR and AKT pathways in parallel.11 Here, AKT1 is linked to lung carcinoma.